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Abstract
Objectives: The purpose of the present study is to examine the role of the outcome of the labial salivary gland 
biopsy (LSGB) in the diagnostic procedure of patients suspected of suffering from Sjögren’s syndrome (SS).
Material and Methods: In a retrospective study the result of histopathological assessment of 94 consecutively taken 
labial salivary gland biopsies has been examined. For the diagnosis of SS the American-European Consensus 
Group classification (AECG, 2002) have been used. The outcome of the assessment has been discussed in relation 
to a recently reported classification provided by the American College of Rheumatology (ACR, 2012). 
Results: In the 94 LSGBs support for a diagnosis of SS has been encountered in 24 out of  26 patients with SS. In 
the 68 patients with a negative diagnosis of SS only six positive LSGBs were observed. The sensitivity of the labial 
biopsy amounted  0.92; the specificity was 0.91, while the positive predictive value and the negative predictive 
value amounted 0.80 and 0.97 respectively.  LSGBs taken by or on the request of the departments of Rheumatology 
or Internal Medicine had a significant higher yield compared to LSGBs taken in other clinical departments.
Conclusions: The LSGB may play a  role in the diagnostic procedure of Sjögren’s syndrome when using either the 
AECG classification or the ACR classification. A LSGB should preferably taken after counseling for the possible 
presence of SS by a department of Rheumatology or Internal Medicine since the yield of such biopsies is much 
higher than in patients who have not been counseled by these departments prior to the taking of a LSGB. 
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When using the ACR classification, a positive serologic result and a positive ocular test make the taking of a LSGB 
redundant. Only in case of a negative serologic outcome or a negative result of the ocular test  a LSGB is indicated. 
Since both the serologic test and the ocular test carry hardly any morbidity, these tests should, indeed, be performed 
first before considering to take a LSGB.
Key words: Labial salivary gland biopsy, Sjögren’s syndrome.
Introduction  
Sjögren’s syndrome (SS) is a multiorgan, chronic 
autoimmune disease, primarily directed against 
exocrine glands, being characterized by dry mouth and 
dry eyes. Histopathologically, clusters of monocellular 
immune cells are present in the exocrine glandular 
tissues, leading to atrophy. In  SS fatigue, arthritis and 
kidney failure may occur and, as a late complication, 
the development of   non-Hodgkin lymphoma. However, 
the majority of these ‘signature’ symptoms may also 
be related to other diseases. SS may have a genetic 
predilection, as well as hormonal and environmental 
etiological factors. All of this adds to the complexity of 
the disease (1,2).
SS may exist as a single condition, being called primary 
Sjögren’s syndrome (pSS). Sjögren’s syndrome can also 
be associated with other autoimmune diseases, being 
referred to as secondary Sjögren’s syndrome (sSS). 
The prevalence of SS is estimated to be 0,5-1% of the 
population; there is a distinct female preponderance 
(3). 
In the past decades several diagnostic criteria have 
been proposed to facilitate the diagnosis of SS. The 
most commonly used classification is the one proposed 
by the American-European Consensus Group (AECG) 
(1). Of the six diagnostic criteria in this classification 
at least four should be positive in order to qualify for 
a diagnosis of SS. The histopathological findings in a 
biopsy of the labial salivary glands, usually taken from 
the lower lip, is one of the six criteria. A positive labial 
salivary gland biopsy (LSGB) should have a focus score 
of more than one. A focus is defined as the presence of 
a cluster of at least 50 lymphocytes per 4 mm2 glandular 
tissue adjacent to normal appearing mucous acini.
The purpose of the present study is to examine the role 
of the outcome of the LSGB in the 
diagnostic procedure of patients suspected of suffering 
from SS.
Material and Methods
In the files of the department of pathology of the VU 
university medical center, Amsterdam, the Netherlands, 
139 consecutive labial salivary gland biopsies (LSGBs) 
could be retrieved in the period  between 2000 and 
2010. Demographic, clinical and laboratory data from 
these patients were obtained from the medical records. 
Out of these 139 cases, 45 patients have been excluded 
because of incomplete data. As a result 94 patients have 
been included in the study. There were 74 females and 
20 males; the mean age at the time of biopsy was 50 
years (range 21 to 79 years). For the diagnosis of SS the 
AECG criteria have been used (4). The histopathological 
assessment of the presence of lymphocytic foci in the 
labial salivary gland biopsies has been performed in a 
quantitative way (5). For the statistical analyses SPSS 
21.0 for Windows was used, calculating the Pierson’s chi-
squared test. 
The design of this study adheres to the code for proper 
secondary use of human tissue of the Dutch Federation of 
Biomedical Scientific Societies (http://www.federa.org).
Results
The overall results of the various diagnostic tests are 
listed in table 1. Of the 26 SS positive patients the mean 
age is 47 years.
Of the 64 negative labial biopsies four did not contain 
sufficient glandular tissue to allow a focus score.  The 
sensitivity of the labial biopsy amounted 0.92; the 
specificity was 0.91, while the positive predictive value 
and the negative predictive value amounted 0.80 and 
0.97 respectively.
In table 2 the results of the various diagnostic tests in 
the patients with a final diagnosis of SS, divided in 
primary (n=20) and secondary (n=2) SS are shown. In 
four patients no reliable data could be retrieved from the 
clinical records to allow a distinction between primary 
and secondary SS. Apparently, the results of the salivary 
flow test have not been recorded or this test has not been 
performed in all but a few patients.  
The percentages of positive labial biopsies  for each 
department are shown in table 3. The percentage of 
positive LSGBs was significantly higher in patients in 
whom the biopsy was performed by or on the request 
of either the department of Rheumatology and Internal 
Medicine compared to patients who had not been 
counseled by these departments prior to the taking of 
the LSGB (p < 0,05).
The comparison of the result of the labial biopsy and 
the serology obtained in the 20 patients diagnosed 
with primary Sjögren syndrome shows that in case 
of a positive LSGB (n=19) the serology was positive 
in 80% per cent of the cases, while in patients with a 
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Positive
SS (n=26) 
Negative
SS (n=68) 
Total
(n=94) 
AECG Criteria (4)    
I. Ocular complaints 
Positive 22 41 63 
Negative 4 27 31 
II. Oral complaints 
Positive 25 52 77 
Negative 1 16 17 
III. Schirmer I test 
Positive 18 23 41 
Negative 1 11 12 
Not performed 7 34 41 
IV. Labial biopsy  
Positive 24 6 30 
Negative 2 62 64 
V. Salivary flow 
Positive 2 6 8 
Negative 2 1 3 
Not performed 22 61 83 
VI. Auto - antibodies 
Positive 20 13 33 
Negative 5 35 40 
Not performed/  unclear 1 20 21 
Table 1.  Results of the various diagnostic tests in 94 patients in whom a labial salivary gland 
biopsy has been performed.
Patient
number 
I. Ocular 
complaints
II. Oral 
complaints
III. Schirmer 
I test 
IV. Labial 
biopsy 
V. Salivary 
flow 
VI. Auto - 
antibodies M/F 
1 positive positive positive positive negative negative F 
2 positive positive - positive - positive F 
3 positive positive positive positive - positive F 
4 positive positive - positive - positive F 
5 positive positive - positive - positive F 
6 negative positive positive positive - positive F 
7 positive negative positive positive - positive F 
8 positive positive - positive - positive F 
9 positive positive positive positive - negative F 
10 positive positive positive negative - positive M 
11 - positive negative positive positive positive M 
12 positive positive positive positive - positive F 
13 positive positive positive positive - positive F 
14 positive positive positive positive - positive F 
15 positive positive - positive negative positive F 
16 negative positive positive positive - positive F 
17 positive positive positive positive - negative M 
18 positive positive positive positive - positive F 
19 positive positive positive positive - - F 
20 negative positive - positive positive positive F 
21 positive positive positive positive - - M 
22 positive positive positive positive -- - F 
Table 2. The results of the various diagnostic tests in 20 patients with primary SS (#1-20) and two patients with secondary SS (#21 and 
22).
- Not recorded or not performed.
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positive serology (n=16) only one negative LSGB was 
encountered. In case of a negative result of the serology 
(n=4) a positive LSGB was observed in three patients.
Discussion and Conclusions
The present study has been undertaken for two reasons. 
Firstly, we wanted to examine in what way labial bi-
opsies taken in our Institution in a 10-year period had 
contributed to the assessment of a diagnosis of Sjögren’s 
syndrome. Secondly, we wanted to explore the influence 
of the recently proposed ACR criteria with regard to the 
role of the LSGB.
Of the 94 LSGBs that were suitable for evaluation only 
26 have contributed to a final diagnosis of SS. As can 
be seen from the figures in table 1 the Schirmer I test 
has been performed in approximately half of the pa-
tients only. Measurement of the salivary flow has been 
performed in only 12 percent of the patients. This is re-
markably since a LSGB carries some degree of morbid-
ity; some two per cent of patients experience long term 
postoperative complaints of numbness or hyperaesthe-
sia at the site of the biopsy (6). 
As is shown in table 3, the yield of LSGBs has been 
significant higher in patients in whom the biopsy was 
performed by or by the request from the departments 
of Rheumatology or the department of Internal Medi-
cine than in patients in whom the biopsies were taken in 
other departments, not by the request from the depart-
ments of Rheumatology or Internal Medicine. There-
fore, it seems advisable to perform LSGBs only after 
counseling of the patients by the departments of Rheu-
matology or Internal Medicine.
Our results show a high specificity and a high sensitivi-
ty of the LSGB with regard to the presence of SS (Table 
1). These results are somewhat similar to the outcome of 
a study by Baeteman e.a., who calculated an even higher 
specificity of 1,00 and a sensitivity of 0,75 (7). It is well 
recognized that the assessment of a focus score, when 
performed in a semiquantitive fashion, carries room for 
discussion about its value (8,9). In postmortem studies 
older age was associated with high false-positive rates 
of LSGB (10). Iin view of a mean age of  50 years at the 
time of the biopsy, age does not seem to have a major 
influence on the present results.  
In the past, it has been suggested that immunohisto-
chemical assessment of the various percentages of im-
munoglobulins in the plasma cells, such as IgA, IgG and 
IgM, has a prognostic significance with regard to future 
development of malignant lymphoreticular disease (11); 
the same research group has shown that quantitative im-
munohistologic criteria are superior to the lymphocytic 
focus score for the diagnosis of SS (12). However, no 
other studies on these two subjects have been published 
and they have not been incorporated in the AECG clas-
sification nor in the ACR classification.
In 2012 a revised classification has been proposed by 
the American College of Rheumatology (ACR) in which 
the subjective criteria of dry mouth and dry eyes have 
been deleted, focusing on 1) serologic findings, 2) a fo-
cus score in labial salivary gland biopsies, and 3) ocular 
signs (13). Furthermore, no distinction is made in this 
classification between primary and secondary SS. For 
the assessment of the ocular signs in the ACR classifica-
tion ocular surface staining has been performed instead 
of a Schirmer test.  In a study comparing the two clas-
sifications (AECG versus ACR) no significant differ-
ence was found between the diagnostic value of these 
two classifications (14). When using the ACR classifi-
cation, a positive serologic result and a positive ocular 
test make the taking of a LSGB redundant (15,16). Only 
in case of a negative serologic outcome or a negative 
result of the ocular test  a LSGB is indicated. Since both 
Number 
of labial 
biopsies
Number of positive 
diagnosed SS 
patients (n=26)* 
Number of negative 
diagnosed SS patients 
(n=68) 
Rheumatology, Internal 
Medicine and Oral and 
Maxillofacial Surgery (only by 
request of the depts. of 
Rheumatology or Internal 
Medicine)  
62 23   (37%) 39 (63%) 
Other departments (not by the 
request of the depts. of 
Rheumatology or Internal 
medicine), e.g. Otolaryngology, 
Dermatology, Plastic surgery, 
Ophthalmology  
32 3   (9%) 29 (91%) 
Table 3.  Result of labial salivary gland biopsy per department groups.
*The difference in the percentages of positive biopsies between the two different department groups is significant 
(p ≤ 0.05).
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the serologic test and the ocular test carry hardly any 
morbidity, these tests should be performed first before 
considering to take a LSGB.
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